Assignee
SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD
CN·5 granted patents·5 pending applications·2 citations·filing 2017–2021
Top patents by PatentIndex Score
10 records- 0171US11168055B2Endocyclic thiamidinoamide-arylamide compound and use thereof for treating hepatitis BSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted Nov 9, 2021·1 cites·17 claims
- 0268US11524961B2JAK kinase inhibitor and preparation method and use thereofSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted Dec 13, 2022·1 cites·5 claims
- 0350US2023357219A1Preparation of biaryl ring-linked aromatic heterocyclic derivative as immunomodulator and use thereofSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0448US2022380384A1Internal cyclic sulphiamidine amide-aryl amide compound and use thereof for treating hepatitis bSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 0545US2023278993A1Novel tricyclic aromatic heterocyclic compound and preparation method therefor, pharmaceutical composition and use thereofSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0644US11299460B2MDM2 inhibitor, preparation method therefor, pharmaceutical composition thereof and use thereofSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2019·Granted Apr 12, 2022·0 cites·10 claims
- 0743US2022370429A1Aromatic heterocyclic compound having tricyclic structure, and preparation method therefor and application thereofSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 0843US2022372031A1Novel tricyclic aromatic heterocyclic compound, preparation method therefor, pharmaceutical composition and application thereofSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 0938US11370766B2Sulfonyl amidine as indoleamine-2,3-dioxygenase inhibitor, and preparation method therefor and use thereofSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2017·Granted Jun 28, 2022·0 cites·15 claims
- 1035US11591334B2Substituted pyrrolizines for the treatment of hepatitis BSHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted Feb 28, 2023·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →